Drug-induced steatohepatitis leading to cirrhosis: Long-term toxicity of amiodarone use

Seminars in Liver Disease

Volumn 29, Issue 4, 2009, Pages 423-428

  Raja, Kaiser ^a   Thung, Swan N ^b   Fiel, M Isabel ^b   Chang, Charissa ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Amiodarone; Cirrhosis; Hepatotoxicity; Phospholipidosis; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMIODARONE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CENTROMERE ANTIBODY; CREATININE; ESOMEPRAZOLE; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; GLIMEPIRIDE; ISOSORBIDE DINITRATE; LEVOTHYROXINE; LIPID; LISINOPRIL; NITRIC OXIDE; PROPRANOLOL; SPIRONOLACTONE;

ABDOMINAL DISTENSION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANTIBODY TITER; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; BILIRUBIN BLOOD LEVEL; CARDIOMEGALY; CASE REPORT; CHRONIC TOXICITY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC IMAGING; DIASTOLIC DYSFUNCTION; DIFFERENTIAL DIAGNOSIS; DYSPNEA; ESOPHAGUS VARICES BLEEDING; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEPATOGRAPHY; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; INTERNATIONAL NORMALIZED RATIO; LEG SWELLING; LEUKOCYTE COUNT; LIGATION; LIPID BLOOD LEVEL; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HYPERTROPHY; LIVER TOXICITY; MUSCLE ATROPHY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PLEURA EFFUSION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SKIN EXAMINATION; SKIN TIGHTNESS; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART MURMUR; TELANGIECTASIA; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DRUG-INDUCED LIVER INJURY; ESOPHAGEAL AND GASTRIC VARICES; FATTY LIVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; RECURRENCE; TIME FACTORS;

EID: 70449103048     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0029-1240011     Document Type: Article

References (25)

1. Babatin M, Lee S S., Pollak P T. Amiodarone hepatotoxicity. Curr Vasc Pharmacol 2008 6 (3) 228-236
2. Lewis J H., Ranard R C., Caruso A et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989 9 679-685
3. Stravitz R T., Sanyal A J. Drug-induced steatohepatitis. Clin Liver Dis 2003 7 (2) 435-451
4. Vorperian V R., Havighurst T C., Miller S, January C T. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997 30 (3) 791-798
5. Llanos L, Moreu R, Peir A M. et al. Causality assessment of liver injury after chronic oral amiodarone intake. Pharmacoepidemiol Drug Saf 2009 18 (4) 291-300
6. Kum L C., Chan W W., Hui H H. et al. Prevalence of amiodarone-related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction. Clin Cardiol 2006 29 (7) 295-299
7. Giannattasio F, Salvio A, Varriale M, Picciotto F P., Di Costanzo G G., Visconti M. Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity. Ann Ital Med Int 2002 17 (3) 180-184
8. Rhodes A, Eastwood J B., Smith S A. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle? Gut 1993 34 (4) 565-566
9. James P R., Hardman S M. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy. Heart 1997 77 (6) 583-584
10. Fogoros R N., Anderson K P., Winkle R A., Swerdlow C D., Mason J W. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation 1983 68 (1) 88-94
11. Robinson K, Mulrow J P., Rowland E, McKenna W J. Long-term effects of amiodarone on hepatic function. Am J Cardiol 1989 64 (1) 95-96
12. Chang C C., Petrelli M, Tomashefski J F. Jr, McCullough A J. Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature. Arch Pathol Lab Med 1999 123 (3) 251-256
13. Flaharty K K., Chase S L., Yaghsezian H M., Rubin R. Hepatotoxicity associated with amiodarone therapy. Pharmacotherapy 1989 9 (1) 39-44
14. Hilleman D, Miller M A., Parker R, Doering P, Pieper J A. Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 1998 18 (6 Pt 2) 138S-145S
15. Bach N, Schultz B L., Cohen L B. et al. Amiodarone hepatotoxicity: progression from steatosis to cirrhosis. Mt Sinai J Med 1989 56 (4) 293-296
16. Brien J F., Jimmo S, Brennan F J., Ford S E., Armstrong P W. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol 1987 65 (3) 360-364
17. Lewis J H., Mullick F, Ishak K G. et al. Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 1990 21 (1) 59-67
18. Rigas B, Rosenfeld L E., Barwick K W. et al. Amiodarone hepatotoxicity. A clinicopathologic study of five patients. Ann Intern Med 1986 104 (3) 348-351
19. Puli S R., Fraley M A., Puli V, Kuperman A B., Alpert M A. Hepatic cirrhosis caused by low-dose oral amiodarone therapy. Am J Med Sci 2005 330 (5) 257-261
20. Jones D B., Mullick F G., Hoofnagle J H., Baranski B. Reye's syndrome-like illness in a patient receiving amiodarone. Am J Gastroenterol 1988 83 (9) 967-969
21. Guigui B, Perrot S, Berry J P. et al. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 1988 8 (5) 1063-1068
22. Pirovino M, Mller O, Zysset T, Honegger U. Amiodarone-induced hepatic phospholipidosis: correlation of morphological and biochemical findings in an animal model. Hepatology 1988 8 (3) 591-598
23. Kaufmann P, Trk M, Hnni A, Roberts P, Gasser R, Krhenbhl S. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology 2005 41 (4) 925-935
24. Fromenty B, Fisch C, Berson A, Letteron P, Larrey D, Pessayre D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 1990 255 (3) 1377-1384
25. Fromenty B, Fisch C, Labbe G et al. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1990 255 (3) 1371-1376